Abstract

BackgroundAdvances in the characterization and determination of AgNPs in different matrices, investigations involving biological matrices such as urine, plasma, sweat, and saliva still need more studies for routine application. AimThe present study aimed to investigate silver nanoparticles (AgNPs) sizing in human matrices (blood plasma, sweat, urine, and saliva) by Single Particle Inductively Coupled Plasma Mass Spectrometry (spICP-MS). The influence of sample dilution, NPs concentration, storage time were studied. MethodsBlood, plasma, urine and sweat were collected from healthy volunteers aged 20–30 years. The samples were then diluted 1:20 (urine, saliva and plasma) and 1:10 (sweat) in an aqueous solution of AgNPs. After the dilutions, the samples were analyzed by spICP-MS. At the end of the analyzes, the samples were stored at room temperature (25 °C), and another at -5 °C to evaluate the stability of the AgNPs. ResultsHigher concentrations of AgNPs in solution caused interference of matrix compatibility due to Ag+ detection by spICP-MS. Storage time up to 144 h for AgNPs 2 µg L − 1 solutions in 1:20 diluted urine and water was suitable for AgNPs detection. Otherwise, AgNPs 2 µg L − 1 did not present a clear signal-background differentiation in a 1:20 plasma diluted solution after a storage time of 144 h. ConclusionThis study provided new knowledge for monitoring of AgNPs in biological samples, helping with the new regulations proposed by Environmental and Health Agencies.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.